Medical Digest & Congress Report

Dr. Diane van der Woude provides a fascinating expert overview of the discovery of novel autoantibodies and their clinical translation in rheumatic and musculoskeletal diseases (RMDs), presented at the EULAR 2026 Congress. This recap highlights the latest breakthroughs in biomarker identification, how these emerging antibody profiles refine early diagnosis and risk stratification, and their practical implications for guiding highly targeted, personalized treatment pathways.

Video: https://medicaldigest.org/scientific-contents/interview:unveiling-novel-antibodies-and-their-practical-implication-rmds

Rikke Helene Moe, EULAR Vice-President HPR, delivers an inspiring expert overview of the vital role Health Professionals in Rheumatology (HPR) play in transforming patient care, highlighted at the EULAR 2026 Congress. This brief focuses on the latest advancements in structured patient education, comprehensive support frameworks, and innovative multi-disciplinary strategies aimed at breaking down barriers and significantly improving access to high-quality rheumatology care.

Video: https://medicaldigest.org/scientific-contents/interview:hpr-patient-education-support-and-improving-access-rheumatology-care

Dr. Jasminka Milas-Ahic provides a comprehensive expert overview of the contemporary challenges and advancements in pain management across rheumatological diseases, presented at the EULAR 2026 Congress. This recap explores the critical shift toward multimodal treatment strategies, the integration of pharmacological and non-pharmacological interventions, and how addressing centralized pain mechanisms is vital to improving long-term patient outcomes and quality of life.

Video: https://medicaldigest.org/scientific-contents/interview:pain-management-rheumatological-diseases

Dr. Claudia Iannone delivers a vital expert perspective on the strategic management of comorbidities in patients with Systemic Sclerosis, featured at the EULAR 2026 Congress. This brief emphasizes the profound impact of overlapping systemic, cardiovascular, and metabolic complications on disease progression, highlighting the integrated care approaches and proactive screening protocols essential for optimizing long-term therapeutic outcomes and patient quality of life.

Video: https://medicaldigest.org/scientific-contents/interview:managing-comorbidities-systemic-sclerosis-achieve-better-outcome

Dr. Claudia Iannone delivers a vital expert perspective on the strategic management of comorbidities in patients with Rheumatoid Arthritis, featured at the EULAR 2026 Congress. This brief emphasizes the profound impact of cardiovascular, metabolic, and mental health conditions on RA progression, highlighting integrated care approaches and early screening protocols essential for optimizing long-term therapeutic outcomes and patient quality of life.

Video: https://medicaldigest.org/scientific-contents/interview:managing-comorbidities-rheumatoid-arthritis-better-outcome

Dr. Anca Dinu Askanase provides an essential expert overview of the latest breakthrough advancements and novel therapeutic developments in the treatment of Systemic Lupus Erythematosus (SLE), presented at the EULAR 2026 Congress. This recap highlights the evolving paradigm of targeted biologics, innovative small molecules, and combination strategies designed to achieve deeper clinical remission, minimize steroid dependency, and prevent long-term organ damage.

Video: https://medicaldigest.org/scientific-contents/interview:novel-development-treatment-lupus

Professor Xenofon Baraliakos, President of EULAR, presents pivotal data from a Phase 2 study evaluating the impact of sonelokimab, an IL-17A/F-inhibiting Nanobody, on clinical outcomes in axial spondyloarthritis. Highlighted at the EULAR 2026 Congress, this breakthrough recap explores how the integration of advanced 18F-NaF PET imaging and MRI provides unprecedented visualization of reduced bone inflammation and metabolic activity, opening new pathways for targeted biologic therapies.

Video: https://medicaldigest.org/scientific-contents/interview:impact-sonelokimab-clinical-and-imaging-outcomes-axial-spondyloarthritis-results-phase-2-study

Dr. Laura Andreoli and Dr. Karen Schreiber share essential insights from EULAR 2026 on managing fertility and family planning in patients with rheumatic and musculoskeletal diseases (RMDs). This recap explores clinical strategies from early diagnosis to pregnancy, focusing on safe medication management, patient counseling, and the multidisciplinary support needed to ensure positive maternal and fetal outcomes.

Video: https://medicaldigest.org/scientific-contents/interview:diagnosis-family-building-navigating-fertility-rmds

Dr. Victoria Werth provides a concise update on the rapidly evolving therapeutic landscape for lupus, highlighting breakthrough data from EULAR 2026. This recap focuses on novel, targeted therapies designed to address unmet needs in both systemic (SLE) and cutaneous lupus (CLE), exploring how these precision strategies are successfully reshaping disease modification.

Video: https://medicaldigest.org/scientific-contents/interview:novel-treatment-horizons-lupus-key-updates-eular-2026

Professor Xenofon Baraliakos, President of EULAR, delivers an authoritative executive summary of the definitive highlights from the EULAR 2026 Congress in London. Reflecting on a record-breaking year of scientific submissions, this overview captures the most impactful advancements spanning basic translational research, groundbreaking clinical trials in rheumatology, and newly updated management guidelines, emphasizing a 360-degree approach to bridging the gap between bench research and routine clinical practice.

Video: https://medicaldigest.org/scientific-contents/interview:highlights-eular-2026